Morgan Stanley Matinas Bio Pharma Holdings, Inc. Call Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MTNB
# of Institutions
6Shares Held
3.52MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.48MShares$1.41 Million0.0% of portfolio
-
Jtc Employer Solutions Trustee LTD775KShares$441,7490.0% of portfolio
-
Kingsbury Capital Investment Advisors LLC Evanston, IL120KShares$68,3700.12% of portfolio
-
Hyman Charles D79.8KShares$45,4850.0% of portfolio
-
Sawtooth Solutions, LLC60KShares$34,2090.0% of portfolio
About Matinas BioPharma Holdings, Inc.
- Ticker MTNB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,864,992
- Market Cap $124M
- Description
- Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...